Literature DB >> 1457329

Altered in vitro lymphocyte response in childhood nephrotic syndrome.

I K Hewitt1, A K House, J M Potter, B F Kinnear.   

Abstract

The immune system, and disturbed T lymphocyte function in particular, has previously been implicated in the pathogenesis of childhood idiopathic nephrotic syndrome. As this disorder is commonly responsive to steroid therapy, we set out to determine whether in vitro suppression of lymphocyte blastogenic response to the mitogen phytohaemagglutinin (PHA) could predict the clinical situation. Comparing nine nephrotic children with nine healthy controls we were able to show the inhibitory prednisolone dose that suppressed lymphocyte blastogenesis by 50% (ID50) at a known concentration of PHA was significantly greater (P < 0.005) for nephrotic individuals. However, the in vitro assay did not reliably predict the clinical response to prednisolone. This study further implicates altered lymphocyte function in the mechanisms underlying idiopathic nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457329     DOI: 10.1007/bf00874015

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

Review 1.  The pathogenesis of minimal change nephropathy.

Authors:  N P Mallick
Journal:  Clin Nephrol       Date:  1977-03       Impact factor: 0.975

2.  Variable inhibition of mitogen-induced blastogenesis in human lymphocytes by prednisolone in vitro.

Authors:  K B Walker; J M Potter; A K House
Journal:  Transplant Proc       Date:  1985-04       Impact factor: 1.066

3.  Pathogenesis of lipoid nephrosis: a disorder of T-cell function.

Authors:  R J Shalhoub
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

4.  Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome.

Authors:  A V Moorthy; S W Zimmerman; P M Burkholder
Journal:  Lancet       Date:  1976-05-29       Impact factor: 79.321

5.  Suppressor T-lymphocyte dysfunction in MCNS: role of the H2 histamine receptor-bearing suppressor T lymphocytes.

Authors:  Z Inage; N Wada; Y Kikkawa; M Inami; H Hirose; T Kitagawa
Journal:  Clin Nephrol       Date:  1990-01       Impact factor: 0.975

6.  A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome.

Authors:  G Lagrue; S Xheneumont; A Branellec; G Hirbec; B Weil
Journal:  Biomedicine       Date:  1975-02-10

7.  Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children.

Authors:  H W Schnaper; T M Aune
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Impaired IgG synthesis in patients with the nephrotic syndrome.

Authors:  J M Heslan; J P Lautie; L Intrator; C Blanc; G Lagrue; A T Sobel
Journal:  Clin Nephrol       Date:  1982-09       Impact factor: 0.975

9.  Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome.

Authors:  J Giangiacomo; T G Cleary; B R Cole; P Hoffsten; A M Robson
Journal:  N Engl J Med       Date:  1975-07-03       Impact factor: 91.245

10.  Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance.

Authors:  K B Walker; J M Potter; A K House
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

View more
  2 in total

1.  Urinary annexin V in children with nephrotic syndrome: a new prognostic marker?

Authors:  Behcet Simsek; Mithat Buyukcelik; Mustafa Soran; Aysun K Bayazit; Aytul Noyan; Gulsah Seydaoglu; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2007-11-13       Impact factor: 3.714

2.  T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Authors:  Diego H Aviles; Matti V Vehaskari; Kirk S Culotta; Jennifer Manning; Augusto C Ochoa; Arnold H Zea
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.